Page 192 - Hematology_ Basic Principles and Practice ( PDFDrive )

144.e6 Part II Cellular Basis of Hematology

237. Cyster JG: B cell follicles and antigen encounters of the third kind. Nat 254. Milling S, Yrlid U, Cerovic V, et al: Subsets of migrating intestinal
Immunol 11(11):989–996, 2010. dendritic cells. Immunol Rev 234(1):259–267, 2010.
238. Fooksman DR, Schwickert TA, Victora GD, et al: Development 255. Salmi M, Koskinen K, Henttinen T, et al: CLEVER-1 mediates lym-
and migration of plasma cells in the mouse lymph node. Immunity phocyte transmigration through vascular and lymphatic endothelium.
33(1):118–127, 2010. Blood 104(13):3849–3857, 2004.
239. Pereira JP, Kelly LM, Cyster JG: Finding the right niche: B-cell migra- 256. Zhi L, Kim P, Thompson BD, et al: FTY720 blocks egress of T cells
tion in the early phases of T-dependent antibody responses. Int Immunol in part by abrogation of their adhesion on the lymph node sinus. J
22(6):413–419, 2010. Immunol 187(5):2244–2251, 2011.
240. Manevich-Mendelson E, Grabovsky V, Feigelson SW, et al: Talin1 is 257. Brinkmann V, Lynch K: FTY720: targeting G-protein-coupled recep-
required for integrin-dependent B lymphocyte homing to lymph nodes tors for sphingosine 1- phosphate in transplantation and autoimmunity.
and the bone marrow but not for follicular B-cell maturation in the Curr Opin Immunol 14(5):569, 2002.
spleen. Blood 116(26):5907–5918, 2010. 258. Kappos L, Antel J, Comi G, et al: Oral fingolimod (FTY720) for
241. Lu TT, Cyster JG: Integrin-mediated long-term B cell retention in the relapsing multiple sclerosis. N Engl J Med 355(11):1124–1140,
splenic marginal zone. Science 297(5580):409–412, 2002. 2006.
242. Cinamon G, Matloubian M, Lesneski MJ, et al: Sphingosine 259. Brinkmann V, Billich A, Baumruker T, et al: Fingolimod (FTY720):
1-phosphate receptor 1 promotes B cell localization in the splenic discovery and development of an oral drug to treat multiple sclerosis.
marginal zone. Nat Immunol 5(7):713–720, 2004. Nat Rev Drug Discov 9(11):883–897, 2010.
243. Alvarez D, Vollmann EH, von Andrian UH: Mechanisms and conse- 260. Rosen H, Goetzl EJ: Sphingosine 1-phosphate and its receptors: an
quences of dendritic cell migration. Immunity 29(3):325–342, 2008. autocrine and paracrine network. Nat Rev Immunol 5(7):560–570,
244. Cravens PD, Lipsky PE: Dendritic cells, chemokine receptors and 2005.
autoimmune inflammatory diseases. Immunol Cell Biol 80(5):497–505, 261. Spiegel S, Milstien S: Sphingosine-1-phosphate: an enigmatic signalling
2002. lipid. Nat Rev Mol Cell Biol 4(5):397–407, 2003.
245. Sozzani S, Allavena P, Vecchi A, et al: Chemokines and dendritic cell 262. Ledgerwood LG, Lal G, Zhang N, et al: The sphingosine 1-phosphate
traffic. J Clin Immunol 20(3):151–160, 2000. receptor 1 causes tissue retention by inhibiting the entry of peripheral
246. Kawai T, Akira S: Innate immune recognition of viral infection. Nat tissue T lymphocytes into afferent lymphatics. Nat Immunol 9(1):42–53,
Immunol 7(2):131–137, 2006. 2008.
247. Granucci F, Foti M, Ricciardi-Castagnoli P: Dendritic cell biology. Adv 263. Matloubian M, Lo CG, Cinamon G, et al: Lymphocyte egress from
Immunol 88:193–233, 2005. thymus and peripheral lymphoid organs is dependent on S1P receptor
248. Macagno A, Napolitani G, Lanzavecchia A, et al: Duration, combina- 1. Nature 427(6972):355–360, 2004.
tion and timing: the signal integration model of dendritic cell activa- 264. Chi H: Sphingosine-1-phosphate and immune regulation: trafficking
tion. Trends Immunol 28(5):227–233, 2007. and beyond. Trends Pharmacol Sci 32(1):16–24, 2011.
249. Saeki H, Moore AM, Brown MJ, et al: Cutting edge: secondary 265. Schwab SR, Pereira JP, Matloubian M, et al: Lymphocyte sequestration
lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 through S1P lyase inhibition and disruption of S1P gradients. Science
(CCR7) participate in the emigration pathway of mature dendritic cells 309(5741):1735–1739, 2005.
from the skin to regional lymph nodes. J Immunol 162(5):2472–2475, 266. Spiegel S, Milstien S: The outs and the ins of sphingosine-1-phosphate
1999. in immunity. Nat Rev Immunol 11(6):403–415, 2011.
250. Johnson LA, Jackson DG: Inflammation-induced secretion of CCL21 267. Obinata H, Hla T: Sphingosine 1-phosphate in coagulation and inflam-
in lymphatic endothelium is a key regulator of integrin-mediated mation. Semin Immunopathol 34(1):73–91, 2012.
dendritic cell transmigration. Int Immunol 22(10):839–849, 2010. 268. Grigorova IL, Panteleev M, Cyster JG: Lymph node cortical sinus orga-
251. Haessler U, Pisano M, Wu M, et al: Dendritic cell chemotaxis in nization and relationship to lymphocyte egress dynamics and antigen
3D under defined chemokine gradients reveals differential response to exposure. Proc Natl Acad Sci USA 107(47):20447–20452, 2010.
ligands CCL21 and CCL19. Proc Natl Acad Sci USA 108(14):5614– 269. Shiow LR, Rosen DB, Brdickova N, et al: CD69 acts downstream
5619, 2011. of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from
252. Cera MR, Del Prete A, Vecchi A, et al: Increased DC trafficking to lymphoid organs. Nature 440(7083):540–544, 2006.
lymph nodes and contact hypersensitivity in junctional adhesion 270. Laird DJ, von Andrian UH, Wagers AJ: Stem cell trafficking in tissue
molecule-A-deficient mice. J Clin Invest 114(5):729–738, 2004. development, growth, and disease. Cell 132(4):612–630, 2008.
253. Roediger B, Ng LG, Smith AL, et al: Visualizing dendritic cell migra-
tion within the skin. Histochem Cell Biol 130(6):1131–1146, 2008.